What is Mirion Technologies's market cap?

Mirion Technologies (MIR) has a market capitalization of $4.1B and trades on NYSE.

What is Mirion Technologies's revenue and profitability?

Mirion Technologies generated $1.0B in trailing twelve-month revenue with net income of $24.5M, representing a net margin of 2.4%. Gross margin stands at 48.0%, with free cash flow of $133.7M. These figures are based on the Q2 2026 filing.

Who are Mirion Technologies's competitors?

Mirion Technologies's key competitors include Thermo Fisher Scientific, Landauer, Nano Nuclear Energy Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Mirion Technologies partner with?

Mirion Technologies's notable partners include International Atomic Energy Agency.

What subsidiaries does Mirion Technologies have?

Mirion Technologies's subsidiaries include Certrec Corporation, Paragon Energy Solutions, Oncospace.

Where is Mirion Technologies headquartered?

Mirion Technologies is headquartered in United States of America and employs approximately 3,000 people. It has been publicly traded since 2020.

Mirion Technologies

MIR

Mirion Technologies is a global provider of radiation detection, measurement, analysis, and monitoring solutions across the medical, nuclear power, and defense sectors.

Market cap

$4.12B-20.2%

Revenue$1.0B+15.7%

Net income$24.5M+247%

Free cash flow$133.7M+59.7%

EPS (diluted)$0.10+200%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

July 28, 2026

Revenue$266.8MMiss by $2.5M EPS$0.12Beat by $0.02

Read the full report

Next report

Oct 27, 2026 (in 3 months)

Revenue estimate$276.1M

EPS estimate$0.13

Financials

Q2 2026

Income statement

See full

Revenue$266.8M+19.7%

Gross profit$133.1M+29.9%

Operating income$17.9M+80.8%

Net income$7.7M-7.2%

EPS (diluted)$0.030.0%

Balance sheet

See full

Cash & equivalents$421.6M+60.3%

Total debt$476.6M-0.1%

Total equity$1.8B+24.9%

Total assets$3.5B+28.6%

Cash flow

See full

Operating cash flow$58.5M+372%

CapEx$10.4M+18.2%

Free cash flow$48.1M+1,236%

Valuation & ratios

Valuation

See full

Market cap$4.12B-20.2%

Enterprise value$4.18B-21.9%

P/E168.3×—

P/S4×-1.8×

Profitability

See full

Gross margin48%+1.3pp

Operating margin5.3%+0.1pp

Net margin2.4%—

FCF margin13%+3.6pp

Returns & leverage

See full

Return on equity1.5%—

Debt / equity0.3×-0.1×

Current ratio3.2×+0.7×

Segments

By product

See full

Nuclear power$118.1M+43.8%

Cancer care$62.8M+1.0%

Labs and research$29.1M+6.2%

Other$17.8M-44.7%

By geography

See full

North America$179.1M+28.9%

Europe$85.1M+4.0%

Asia Pacific$2.6M+18.2%

By segment

See full

Nuclear & Safety$186.2M+31.4%

Medical Segment$80.6M-0.7%

Competitors

By market cap

Thermo Fisher Scientific$207.93B+13.6%

BWX Technologies$16.2B+18.1%

SPX Technologies$11.0B+30.2%

FactSet Research Systems$9.5B-39.6%

Fluor$7.2B-22.0%

Novanta$5.0B+11.9%

Mirion Technologies$4.1B-19.8%

Nano Nuclear Energy$875.1M-44.4%

By revenue growth

BWX Technologies+21.4%

SPX Technologies+17.4%

Mirion Technologies+15.7%

FactSet Research Systems+6.6%

Thermo Fisher Scientific+5.6%

Novanta+5.6%

Fluor-8.3%

By net margin

FactSet Research Systems23.21%-0.1pp

Thermo Fisher Scientific15.19%0.0pp

SPX Technologies10.76%+0.6pp

BWX Technologies10.2%-0.2pp

Novanta5.35%-2.1pp

Mirion Technologies2.39%+4.3pp

Fluor2.3%-8.8pp

Profile

Mirion Technologies is a global provider of radiation detection, measurement, analysis, and monitoring solutions across the medical, nuclear power, and defense sectors. The company delivers critical safety hardware, software, and services that enable customers to leverage ionizing radiation for energy production, scientific research, and life-saving medical treatments. Its value proposition is centered on providing reliably precise technologies that meet rigorous regulatory standards in high-stakes environments.

Competitive position

A leading global player with a massive installed base, present in over 98% of nuclear power plants and 80% of cancer centers worldwide.

GeographiesNorth America, Europe, Asia Pacific

Customer segmentsGovernment Agencies, Healthcare Providers, Utility Companies, Research Institutions

Business modelManufacturing, Subscription SaaS, Professional Services, Recurring Maintenance and Calibration

SuppliersSpecialized Electronic Component Suppliers, Raw Material Providers, Software Developers, Precision Engineering Subcontractors

CustomersNuclear Utilities, Oncology Clinics, Military Defense Organizations, Radiopharmaceutical Labs, Regulatory Bodies

CountryUnited States of America

Listed2020

Employees3.0K

CEOThomas D. Logan

SectorIndustrials

IndustryIndustrial - Machinery

Websitemirion.com

FilingsSEC EDGAR

Ask your AI about Mirion Technologies.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mirion Technologies's market cap?: Mirion Technologies (MIR) has a market capitalization of $4.1B and trades on NYSE.
What is Mirion Technologies's revenue and profitability?: Mirion Technologies generated $1.0B in trailing twelve-month revenue with net income of $24.5M, representing a net margin of 2.4%. Gross margin stands at 48.0%, with free cash flow of $133.7M. These figures are based on the Q2 2026 filing.
Who are Mirion Technologies's competitors?: Mirion Technologies's key competitors include Thermo Fisher Scientific, Landauer, Nano Nuclear Energy Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Mirion Technologies partner with?: Mirion Technologies's notable partners include International Atomic Energy Agency.
What subsidiaries does Mirion Technologies have?: Mirion Technologies's subsidiaries include Certrec Corporation, Paragon Energy Solutions, Oncospace.
Where is Mirion Technologies headquartered?: Mirion Technologies is headquartered in United States of America and employs approximately 3,000 people. It has been publicly traded since 2020.